As the world inches closer to a \u00a0revolutionary shift\u00a0 in computing, \u00a0quantum computers\u00a0 are at the forefront of this change. Yet, for scientists to effectively tackle the myriad challenges anticipated for future quantum systems, such as optimization issues, cryptography problems, or advancements in \u00a0artificial intelligence\u00a0, a formidable number of \u00a0qubits\u00a0 will be necessary. Estimates suggest we may need several million qubits\u2014or even hundreds of millions\u2014to fully realize this potential. Currently, the most advanced quantum processor is held by IBM, which boasts just over a thousand qubits, highlighting the significant \u00a0technological hurdles\u00a0 that remain to be surmounted.<\/p>\n
<\/p>\n
Interestingly, there is no singular pathway towards enhancing quantum computing capabilities. Various organizations are exploring different technologies for qubits, each at varying stages of maturity. Major tech companies like IBM, Intel, and Google have heavily invested in \u00a0superconducting qubits\u00a0, while smaller firms such as Atlantic Quantum, IQM, Anyon Systems, Rigetti Computing, and Bleximo are also making strides in this domain.<\/p>\n
<\/p>\n
The sheer number of companies working on this type of quantum bit suggests that superconducting qubits currently hold the most promise and investment, which positions them as a leading technology. While this approach may yield more qubits, it is susceptible to errors compared to \u00a0ion trap qubits\u00a0, which are recognized as a viable alternative. Unlike superconducting qubits that operate at extremely low temperatures\u2014around 20 millikelvins or nearly -273 degrees Celsius\u2014ion trap qubits leverage their unique properties while functioning in a less extreme environment.<\/p>\n
<\/p>\n
Ion trap technology currently serves as the primary alternative to superconducting qubits. Companies like IonQ and Honeywell are prominently advancing in this field, which operates on ionized atoms\u2014atoms that possess a net charge, either positive or negative. This charge enables them to be isolated and confined within an electromagnetic field, comprising the foundation of ion trap technology.<\/p>\n
<\/p>\n
IonQ effectively manipulates the quantum states of its ion trap qubits by cooling them to minimize computational noise, subsequently employing lasers to control these qubits. Notably, IonQ uses individual lasers for each ion, along with a global laser that can influence all ions simultaneously. Honeywell also leverages ionized atoms and lasers, although the process used to establish \u00a0entanglement\u00a0 between two ions differs from the protocol employed by IonQ.<\/p>\n
<\/p>\n
Understanding protein folding is crucial for finding solutions to Alzheimer\u2019s and Parkinson\u2019s disease.<\/p>\n<\/p><\/div>\n<\/div>\n
Recently, a collaborative team from Honeywell and Kipu Quantum, a German startup specializing in quantum computing, achieved a remarkable milestone by employing a 36-qubit ion trap computer to tackle the complex issue of \u00a0protein folding\u00a0 involving up to 12 amino acids. They developed a quantum optimization method aimed at identifying the optimal configurations of protein structures.<\/p>\n
<\/p>\n
Though this endeavor seems daunting\u2014and indeed it is\u2014the crux of the matter lies in the ability of quantum computers, through the right algorithms, to assist scientists in comprehending the intricate mechanisms of protein folding that can lead to debilitating diseases like Alzheimer\u2019s and Parkinson\u2019s. Gaining a deeper understanding of this process is paramount for devising effective treatments.<\/p>\n
<\/p>\n
This promising outcome signifies only the beginning. However, considerable work remains before quantum computers can reliably aid in combating these diseases. Firstly, the models surrounding protein folding must evolve to be more accurate and realistic. Furthermore, the classical algorithms responsible for refining the results generated by quantum algorithms need to be more precise. Despite these ongoing challenges, the achievements of these researchers serve as a profoundly promising springboard for future advancements in \u00a0healthcare\u00a0.<\/p>\n
<\/p>\n
Image | IonQ<\/a><\/p>\n